SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-027582
Filing Date
2021-11-30
Accepted
2021-11-30 19:42:19
Documents
1
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2830
  Complete submission text file 0001437749-21-027582.txt   4297
Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
Pascoe Richard W (Reporting) CIK: 0001343266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 211460914

Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations